Spina Bifida & Myelomeningocele Lifelong Care Coordination

• Detailed fetal ultrasound reports and images.
• Fetal MRI and original imaging files where performed.
• Lesion level and appearance, hindbrain herniation and ventricular measurements.
• Associated fetal abnormalities and placental or maternal findings.
• Genetic counselling, chromosomal or other diagnostic testing.
• Maternal medical and obstetric history.
• Fetal-surgery centre assessment, eligibility discussion and reasons for acceptance or non-selection where applicable.
• Delivery and neonatal-centre plan.

• Open, fetoscopic or other prenatal repair operative records where applicable.
• Maternal postoperative, obstetric and delivery records.
• Gestational age at repair and birth.
• Postnatal myelomeningocele closure operative report and timing.
• Neural placode, meningeal, fascial and skin reconstruction details.
• Wound infection, CSF leak, dehiscence or neonatal intensive-care course.
• Baseline neurological examination before and after closure.

• Brain MRI, CT, cranial ultrasound and DICOM files.
• Hydrocephalus chronology and ventricular trends.
• Shunt manufacturer, valve model, setting, components and revision history.
• ETV or ETV/CPC operative and follow-up records where relevant.
• Chiari II, syringomyelia, brainstem and cranial-nerve findings.
• Previous shunt infection, obstruction, overdrainage and the patient’s typical malfunction symptoms.
• Neurosurgical emergency plan and local treating-centre contacts.

• Whole-spine and lumbosacral MRI/DICOM.
• Functional lesion level and serial neurological examinations.
• Tethered cord, lipoma, split cord, dermal sinus or syrinx documentation.
• Untethering, re-untethering and other spinal operative reports.
• Intraoperative monitoring records where available.
• Change in strength, sensation, gait, pain, bladder, bowel and orthopaedic function before and after surgery.

• Continence, bladder sensation and toilet-training history.
• Clean intermittent catheterization schedule, catheter size and typical volumes.
• Urinary tract infection and culture history.
• Medication, intravesical treatment and botulinum-toxin history.
• Urodynamic reports and tracings, preferably with earlier studies for comparison.
• Post-void residuals, renal and bladder ultrasound, kidney function and upper-tract findings.
• Bladder augmentation, catheterizable channel, bladder-neck or continence procedures.
• Current renal-protection and emergency plan.

Social continence does not necessarily demonstrate safe low-pressure bladder storage. Urodynamics should be interpreted within the complete neuro-urological and renal context.

• Constipation, stool consistency, sensation, leakage and evacuation history.
• Diet, hydration, oral medication, suppository and enema regimen.
• Transanal irrigation or antegrade continence-enema records.
• Colorectal, gastroenterology and pelvic-floor assessments.
• Time required, caregiver support, school or workplace impact and degree of independence.
• Previous abdominal or continence surgery and complications.

• Functional motor level, strength, transfers, endurance and gait videos.
• Orthoses, crutches, walker, wheelchair and seating-system specifications.
• Foot, ankle, knee, hip and contracture assessments.
• Scoliosis, kyphosis and serial standing radiographs.
• Previous orthopaedic procedures and rehabilitation outcomes.
• Upper-limb overuse, pain, fractures, bone health and weight-bearing history.
• Physical and occupational therapy goals.

• Areas of reduced sensation and daily skin-check routine.
• Current or previous pressure injuries, wound photographs and treatment records.
• Orthotic, footwear, seating and transfer-related pressure points.
• Previous flap or wound surgery.
• Documented latex allergy, sensitization or previous reaction.
• Latex-safe catheter, glove and equipment requirements.

• Developmental milestones and school history.
• Neuropsychological, cognitive, attention and executive-function assessments.
• Individual education plan and classroom accommodations.
• Speech, language, vision and hearing records where relevant.
• Mental-health assessment, social participation and family-support needs.
• Ability to learn and carry out catheter, bowel, skin, medication and equipment routines.

• Concise lifetime medical and surgical summary.
• Shunt details and emergency action plan.
• Bladder, bowel, skin, mobility, equipment and supply plans.
• Medication list, allergies and latex precautions.
• Adult neurosurgery, urology, rehabilitation, orthopaedics and primary-care contacts.
• Sexual, reproductive, fertility and pregnancy-related counselling where relevant.
• Decision-making capacity, consent support, insurance, education, employment and independent-living goals.
• Division of responsibilities between the individual, family and care teams.

Myelomeningocele contains neural tissue and is usually associated with neurological impairment below the lesion. Meningocele contains meninges and CSF, with less direct neural involvement. Spina bifida occulta usually refers to a vertebral arch defect without an open sac and often without neurological disability. Closed spinal dysraphisms such as lipomyelomeningocele, dermal sinus, split cord and tethering have their own anatomy and risk profiles. These terms should not be used interchangeably.

Prenatal counselling should describe the lesion, hindbrain and ventricular findings, associated anomalies, genetic testing, maternal health and available treatment pathways. Anatomical lesion level can inform counselling but does not precisely predict an individual child’s future mobility, bladder, bowel, cognitive or independence outcomes. Balanced counselling should include uncertainty and family values.

Prenatal myelomeningocele repair can reduce the likelihood of shunt placement and improve selected motor outcomes in appropriately selected pregnancies. It is not a cure and does not remove the need for lifelong care. It also introduces maternal and fetal risks, including obstetric complications and preterm birth. Eligibility depends on detailed maternal–fetal criteria, gestational age, anatomy and centre expertise.

Open fetal and fetoscopic approaches are technically different and should not be presented as equivalent. Comparative evidence and centre experience continue to evolve. Families should receive centre-specific outcome, complication, delivery and future-pregnancy counselling.

Prenatal or postnatal closure protects exposed neural tissue, reconstructs coverings and reduces infection or further injury risk. Closure does not restore nerves that were already malformed or injured and does not prevent every later complication. Hydrocephalus, Chiari II, neurogenic bladder, orthopaedic needs and tethering may still require long-term surveillance or treatment.

Hydrocephalus is common in open myelomeningocele but treatment is based on clinical and imaging progression, not ventricular size alone. Some patients require a shunt; selected pathways may involve ETV or ETV/CPC. Shunt malfunction or infection can occur at any age and may present with headache, vomiting, drowsiness, vision, cognition, behaviour or functional change. Each patient should have a documented device and emergency plan.

Chiari II is a complex hindbrain malformation associated with myelomeningocele and hydrocephalus; it is not simply a more severe Chiari I. New swallowing, voice, breathing, upper-limb or brainstem symptoms require prompt assessment. Shunt function and hydrocephalus should be evaluated because they may contribute to deterioration before direct Chiari treatment is considered.

The primary urological goals are safe low-pressure storage, effective emptying, prevention of urinary infection where possible and preservation of renal function. A patient can appear continent while bladder pressures remain unsafe, and leakage does not by itself define upper-tract risk. Catheterization, medication, injections and reconstructive procedures are individualized according to bladder and kidney data.

Urodynamics can identify storage pressure, compliance, detrusor activity, outlet coordination and emptying. Centres may use proactive or risk-based surveillance strategies, particularly in early childhood. No single test should be interpreted in isolation. Results should be integrated with catheter volumes, infections, ultrasound, renal function, symptoms and prior studies.

Bowel care may include diet, hydration, oral or rectal medication, transanal irrigation or antegrade continence procedures. The goal is a predictable programme that protects health, supports continence where achievable and fits school, work and social life. Time burden, caregiver dependence, privacy and the individual’s capacity to perform the routine should be part of treatment planning.

Mobility planning considers functional level, strength, contracture, energy cost, skin safety, participation and long-term joint and upper-limb health. Braces, crutches, walkers and wheelchairs can be combined or used differently across environments. Appropriate wheelchair use is not treatment failure; it may improve independence, conserve energy, protect skin and expand participation.

Foot deformity, hip position, contracture, scoliosis and kyphosis are managed according to pain, seating, skin, bracing, mobility and functional goals—not radiographs alone. Surgery should have a defined benefit and account for neurological level, bone quality, wound risk and rehabilitation. Reduced weight-bearing can increase fracture and bone-health concerns.

After myelomeningocele closure, the cord is anatomically attached, but not every patient has symptomatic retethering. New weakness, gait or orthopaedic change, pain, bladder or bowel deterioration may prompt evaluation. Shunt malfunction, Chiari II, syrinx, infection, fracture, pressure injury and other causes should also be considered. MRI appearance alone does not establish active retethering.

Reduced sensation, immobility, moisture, heat, orthoses, footwear and seating can increase skin risk. Prevention includes daily inspection, pressure relief, properly fitted equipment and rapid response to redness or breakdown. A small wound can become a serious infection or barrier to surgery and mobility. Skin care belongs in routine lifelong management.

People with spina bifida can have increased risk of latex sensitization because of repeated medical exposure. Latex allergy and prior reactions should be clearly documented. Catheters, gloves, anaesthetic and procedural supplies should be checked according to the treating centre’s latex-safe protocol. “Latex-free” claims should be verified at the product and care-environment level.

General intelligence can be within the expected range while attention, processing speed, executive function, organisation, visual-spatial learning or self-management remains difficult. Hydrocephalus and other neurological factors can contribute. Neuropsychological assessment and educational support can help translate medical recommendations into routines the individual can realistically perform. Anxiety, depression, social isolation and caregiver burden also require attention.

Transition is a planned transfer of knowledge, responsibility and providers—not simply discharge from a pediatric clinic. The handover should include the lifetime surgical history, shunt and emergency plan, bladder and bowel routines, renal baseline, skin and latex risks, equipment, medication, cognition and decision-making support. Adult providers should be identified before pediatric services end.

Adults may require care for hypertension, obesity, pain, sleep, bone health, renal disease, equipment needs, sexuality, fertility, contraception, pregnancy and ageing with disability. Sexual and reproductive counselling should be accessible and individualized. Pregnancy can affect mobility, skin, bladder, shunt and anaesthetic planning and may require coordinated obstetric, urological, rehabilitation and neurosurgical input.

Outcome should not be reduced to lesion level, walking status or number of operations. Relevant measures include kidney preservation, safe continence management, mobility, skin integrity, education, employment, relationships, mental health, participation, self-determination and the burden of care. The patient’s own goals should guide priorities where medically safe.